Paper36901762
PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases.
Guo X and 8 others. Int J Mol Sci, 2023. Cited by 71 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases. Papers, record 36901762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901762
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanoparticles | Major topic |
| Respiration Disorders | Major topic |
| Respiratory Tract Diseases | Major topic |
| Asthma | Major topic |
| Pulmonary Disease, Chronic Obstructive | Major topic |
| Humans | |
| Polylactic Acid-Polyglycolic Acid Copolymer | |
| Polyglycolic Acid | |
| Lactic Acid | |
| Drug Carriers |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NO. 3D5200117426 | Jilin Provincial Key Laboratory of Pathogen Biology | PubMed | ||
| NO.20200601011JC | Key Laboratory of Precision Infectious Diseases of Jilin Province | PubMed | ||
| NO. 3J1222527426 | Jilin Provincial Development and Reform Commission Common Disease Precision Prevention and Control Engineering Laboratory | PubMed | ||
| 52073278 | National Natural Science Foundation of China | PubMed | ||
| 2022JBGS10 | "Medical Science + X" cross-innovation team of the Norman Bethune Health Science of Jilin Uni-versity | PubMed | ||
| 2021JC036 | Health Commission of Jilin Province | PubMed | ||
| no | Special Funding for Fundamental Scientific Research Business Expenses of Central Universities | PubMed |
Source PubMed
References210
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,015,036 | What Is Cystic Fibrosis? | JAMA | 2022 | https://conductscience.org/library/papers/35015036 | PubMed |
| 2 | 29,466,596 | Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. | JAMA | 2018 | https://conductscience.org/library/papers/29466596 | PubMed |
| 3 | 26,333,936 | Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/26333936 | PubMed |
| 4 | 27,825,867 | Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. | Int J Pharm | 2017 | https://conductscience.org/library/papers/27825867 | PubMed |
| 5 | 15,762,319 | Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions. | J Microencapsul | 2004 | https://conductscience.org/library/papers/15762319 | PubMed |
| 6 | 24,275,949 | RNAi Therapeutic Platforms for Lung Diseases. | Pharmaceuticals (Basel) | 2013 | https://conductscience.org/library/papers/24275949 | PubMed |
| 7 | 32,606,658 | Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers. | Int J Nanomedicine | 2020 | https://conductscience.org/library/papers/32606658 | PubMed |
| 8 | 22,561,837 | Therapies for allergic inflammation: refining strategies to induce tolerance. | Nat Med | 2012 | https://conductscience.org/library/papers/22561837 | PubMed |
| 9 | 33,809,764 | PLGA Based Nanospheres as a Potent Macrophage-Specific Drug Delivery System. | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/33809764 | PubMed |
| 10 | 32,648,899 | Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. | JAMA | 2020 | https://conductscience.org/library/papers/32648899 | PubMed |
| 11 | 19,162,482 | Preventing biofilms of clinically relevant organisms using bacteriophage. | Trends Microbiol | 2009 | https://conductscience.org/library/papers/19162482 | PubMed |
| 12 | 15,970,469 | Infection and inflammation in cystic fibrosis: a short review. | J Cyst Fibros | 2005 | https://conductscience.org/library/papers/15970469 | PubMed |
| 13 | 22,489,704 | Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. | Mol Pharm | 2012 | https://conductscience.org/library/papers/22489704 | PubMed |
| 14 | 34,582,183 | Lung-Targeting Lysostaphin Microspheres for Methicillin-Resistant Staphylococcus aureus Pneumonia Treatment and Prevention. | ACS Nano | 2021 | https://conductscience.org/library/papers/34582183 | PubMed |
| 15 | 26,952,014 | Development and assessment of countermeasure formulations for treatment of lung injury induced by chlorine inhalation. | Toxicol Appl Pharmacol | 2016 | https://conductscience.org/library/papers/26952014 | PubMed |
| 16 | 35,390,488 | Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: Effects of nanoparticle properties. | Int J Pharm | 2022 | https://conductscience.org/library/papers/35390488 | PubMed |
| 17 | 34,112,203 | Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/34112203 | PubMed |
| 18 | 36,016,948 | Advances in the use of exosomes for the treatment of ALI/ARDS. | Front Immunol | 2022 | https://conductscience.org/library/papers/36016948 | PubMed |
| 19 | 33,376,321 | Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment. | Int J Nanomedicine | 2020 | https://conductscience.org/library/papers/33376321 | PubMed |
| 20 | 28,404,617 | Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. | BMJ | 2017 | https://conductscience.org/library/papers/28404617 | PubMed |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,808,126 | Nanostructure driven innovation in diabetes: from enhanced biosensing to smart therapeutic delivery. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42808126 | PubMed |
| 42,694,977 | Deficiency of GLUT1 in macrophages reprograms tumor-associated macrophages to normalize tumor vasculature and retards the progression of tumors. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42694977 | PubMed |
| 42,675,037 | Precision nanomedicine for pulmonary diseases: from molecular targeting to clinical translation. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42675037 | PubMed |
| 42,514,899 | Beyond Antibiotics: The Role of Antimicrobial Polymers in Modern Therapeutics. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514899 | PubMed |
| 41,852,888 | Polymeric anti-platelet carriers for the precision-targeting of age-related cardiovascular and cerebrovascular diseases. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41852888 | PubMed |
| 41,807,762 | Continuous Electrospraying of Inhalable Biological Drug Products: Novel Formulation and Manufacturing Technology. | Pharm Res | 2026 | https://conductscience.org/library/papers/41807762 | PubMed |
| 41,775,929 | Advancing Rare Cancer Therapeutics: Osimertinib-Loaded Inhaled PLGA Nanoparticles for Mesothelioma Treatment. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/41775929 | PubMed |
| 41,533,007 | PLGA nanoparticles restore acidic pH and degradative function to compromised lysosomes with Cy3-labeling providing enhanced tracking to lysosomes. | Am J Physiol Cell Physiol | 2026 | https://conductscience.org/library/papers/41533007 | PubMed |
| 41,510,735 | Formulation Development and In vitro Characterization of Nanoparticles of Pazopanib for Wet Macular Degeneration. | Curr Drug Deliv | 2026 | https://conductscience.org/library/papers/41510735 | PubMed |
| 41,497,188 | Advances in PLGA-Based Drug Delivery Systems for Glioblastoma Treatment. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41497188 | PubMed |
| 41,393,117 | Emerging drug delivery approach using nanomaterials for the treatment of endometrial cancer. | Front Med Technol | 2025 | https://conductscience.org/library/papers/41393117 | PubMed |
| 41,273,167 | Evaluating the Antiviral Efficacy of Encapsulated PKC Inhibitor BIM-I against influenza A Virus Infection. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41273167 | PubMed |
| 41,269,573 | Advances in nanostructured drug delivery systems for cardiovascular therapeutics. | Daru | 2025 | https://conductscience.org/library/papers/41269573 | PubMed |
| 41,230,148 | Prophylactic adjuvant therapy for postoperative recurrence of urethral stricture: a narrative review. | Transl Androl Urol | 2025 | https://conductscience.org/library/papers/41230148 | PubMed |
| 41,058,938 | Targeting Multiple Pathophysiological Axes in COPD: Nanomaterial Advances. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41058938 | PubMed |
| 41,012,548 | Glycyrrhiza uralensis Polysaccharide Gold Nanoparticles as Antigen Carriers and Potential Adjuvant to DC Vaccines. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012548 | PubMed |
| 40,898,368 | Novel pharmaco-exosomal immunotherapy for united airway diseases: PLGA-encapsulated, mesenchymal stem cell-derived exosomes with PPAR-γ agonist for allergic rhinitis and asthma. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40898368 | PubMed |
| 40,844,759 | Amino Acid Transporters in Glioblastoma: Implications for Diagnosis, Disease Monitoring, Therapeutic Targeting, and Drug Delivery. | Mol Diagn Ther | 2025 | https://conductscience.org/library/papers/40844759 | PubMed |
| 40,723,881 | A Novel Microencapsulated Bovine Recombinant Interferon Tau Formulation for Luteolysis Modulation in Cattle. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723881 | PubMed |
| 40,702,523 | PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40702523 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD14 | 929 | PubTator's text mining | https://conductscience.org/library/genes/929 | NCBI Gene |
| CFTR | 1,080 | PubTator's text mining | https://conductscience.org/library/genes/1080 | NCBI Gene |
| CRYAB | 1,410 | PubTator's text mining | https://conductscience.org/library/genes/1410 | NCBI Gene |
| HLA-A | 3,105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| IGHE | 3,497 | PubTator's text mining | https://conductscience.org/library/genes/3497 | NCBI Gene |
| IL1R1 | 3,554 | PubTator's text mining | https://conductscience.org/library/genes/3554 | NCBI Gene |
| IRAK1 | 3,654 | PubTator's text mining | https://conductscience.org/library/genes/3654 | NCBI Gene |
| MIR146A | 406,938 | PubTator's text mining | https://conductscience.org/library/genes/406938 | NCBI Gene |
| TNFAIP3 | 7,128 | PubTator's text mining | https://conductscience.org/library/genes/7128 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36901762
GET https://conductscience.org/api/papers/v1/36901762/references?page=2